PMM2-congenital disorder of glycosylation
Last updated 3 Apr 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
PMM2-congenital disorder of glycosylation (PMM2-CDG, also known as congenital disorder of glycosylation type Ia) is an inherited condition that affects many parts of the body. The type and severity of problems associated with PMM2-CDG vary widely among affected individuals, sometimes even among members of the same family.
Video picks for Genetic conditionsVideo library
Description
PMM2-congenital disorder of glycosylation (PMM2-CDG, also known as congenital disorder of glycosylation type Ia) is an inherited condition that affects many parts of the body. The type and severity of problems associated with PMM2-CDG vary widely among affected individuals, sometimes even among members of the same family.
Individuals with PMM2-CDG typically develop signs and symptoms of the condition during infancy. Affected infants may have weak muscle tone (hypotonia), retracted (inverted) nipples, an abnormal distribution of fat, eyes that do not look in the same direction (strabismus), developmental delay, and a failure to gain weight and grow at the expected rate (failure to thrive). Infants with PMM2-CDG also frequently have an underdeveloped cerebellum, which is the part of the brain that coordinates movement. Distinctive facial features are sometimes present in affected individuals, including a high forehead, a triangular face, large ears, and a thin upper lip. Children with PMM2-CDG may also have elevated liver function test results, seizures, fluid around the heart (pericardial effusion), and blood clotting disorders. About 20 percent of affected infants do not survive the first year of life due to multiple organ failure.
The most severe cases of PMM2-CDG are characterised by hydrops fetalis, a condition in which excess fluid builds up in the body before birth. Most babies with hydrops fetalis are stillborn or die soon after birth.
People with PMM2-CDG who survive infancy may have moderate intellectual disability, and some are unable to walk independently. Affected individuals may also experience stroke-like episodes that involve an extreme lack of energy (lethargy) and temporary paralysis. Recovery from these episodes usually occurs over a period of a few weeks to several months.
During adolescence or adulthood, individuals with PMM2-CDG have reduced sensation and weakness in their arms and legs (peripheral neuropathy), an abnormal curvature of the spine (kyphoscoliosis), impaired muscle coordination (ataxia), and joint deformities (contractures). Some affected individuals have an eye disorder called retinitis pigmentosa that causes vision loss. Females with PMM2-CDG have hypergonadotropic hypogonadism, which affects the production of hormones that direct sexual development. As a result, females with PMM2-CDG do not go through puberty. Affected males experience normal puberty but often have small testes.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Carbohydrate-deficient glycoprotein syndrome type Ia
CDG Ia
CDG1a
CDGS1a
Congenital disorder of glycosylation type Ia
Jaeken syndrome
Phosphomannomutase 2 deficiency
PMM deficiency
PMM2-CDG
Patient picks for Genetic conditions

Children's health
Congenital heart disease
Congenital heart disease is a condition where an abnormality (defect) develops in the heart before birth. There are a number of types of congenital heart defect. Some are mild and cause few problems; others are life-threatening for the baby.
by Dr Mary Harding, MRCGP

Women's health
Ferritin face - signs of low iron, or viral skin trend?
There’s a new viral wellness term in town called ‘ferritin face’. It’s being used to describe the apparent link between low iron stores and symptoms such as dark circles under your eyes, dull, tired-looking skin, cracked lips, and hair loss. But what exactly is ferritin, and can low levels really affect your facial appearance? We spoke to consultant gynaecologist, Dr Lamia Zafrani, and consultant dermatologist, Dr Sidra Khan, to demystify what ferritin is, how it affects our bodies, and why women are more vulnerable to lower levels.
by Hannah Boynton-Forshaw

Hormones
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia is an inherited (genetic) condition causing swelling of the adrenal glands. The condition is associated with a decrease in the blood level of a hormone called cortisol and an increase in the level of male sex hormones (androgens) in both sexes. Some people get a mild condition that produces no symptoms. Others (mainly baby boys) develop a severe form that can be life-threatening. Medical treatment to correct hormone levels is available. Surgery to improve the appearance of unusual genitalia (in girls) is sometimes considered.
by Dr Rosalyn Adleman, MRCGP

Women's health
Endometrial hyperplasia
Endometrial hyperplasia is a thickening of the womb (uterus) lining. The womb lining is called the endometrium. Hyperplasia means over ("hyper" in Latin) growth ("plasia" in Latin).
by Dr Philippa Vincent, MRCGP
%20calculator/og.png)
Healthy living
Glucose Ketone Index (GKI) calculator
Open GKI calculator Want to track your level of ketosis? Use our Glucose Ketone Index (GKI) calculator to assess your metabolic state. Whether you're following a ketogenic diet for weight loss, diabetes management, or therapeutic reasons, this tool gives you a clearer picture of your current glucose–ketone balance.
by Patient infomatics team

Children's health
Congenital pulmonary airway malformation
Congenital pulmonary airway malformation (CPAM) is a rare abnormality of lung development. It is found either in unborn babies or in young babies. The name has recently changed from congenital cystic adenomatoid malformation (CCAM). It is increasingly detected by the routine ultrasound scan during pregnancy. Congenital means present from birth. Pulmonary means related to the lungs. The severity of the abnormality is very variable. Some lesions can shrink or even disappear without treatment. Some lesions cause the baby to have breathing problems very soon after birth. Some lesions cause severe problems for the baby and may have a poor outcome.
by Dr Hayley Willacy, FRCGP
Related patient information and medicines

Patient information leaflet
Glycogen storage disorders
Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. Glycogen storage disorders are a group of inherited diseases that result from a lack of, or abnormal functioning of,.
/og.png)
Patient information leaflet
Temporomandibular Joint Disorder (TMD)
Temporomandibular disorders are problems affecting the jaw joint and the muscles and other tissues around the jaw joint. These disorders usually cause pain or reduced movement of the jaw, and sometimes sounds such as clicking or grating of the jaw joint. There are various causes but generally temporomandibular disorders are not serious and often.

Patient information leaflet
Pituitary gland disorders
This leaflet gives a brief overview of the pituitary gland and the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones. Some of the pituitary gland disorders.

Patient information leaflet
Congenital heart disease
Congenital heart disease is a condition where an abnormality (defect) develops in the heart before birth. There are a number of types of congenital heart defect. What is congenital heart disease. Abnormalities or defects of the heart which develop before birth are together (collectively) called congenital heart disease. Some of these are listed in.

Patient information leaflet
Nephrotic syndrome
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. A syndrome is a set of symptoms and signs that tend to occur together and which can be caused by one or more different diseases. Cross-section diagram of the urinary tract Cross-section diagram of the.

Patient information leaflet
Porphyria
The porphyrias are a group of disorders in which there is a problem with the production of haem (also spelled heme) within the body. There are seven different types of porphyria and in most cases they run in families (are inherited). It is important that the type of porphyria that you have should be identified. Symptoms vary greatly and can.
Further reading and references
- PMM2-congenital disorder of glycosylation; MedlinePlus, National Library of Medicine.
- de Lonlay P, Seta N, Barrot S, Chabrol B, Drouin V, Gabriel BM, Journel H, Kretz M, Laurent J, Le Merrer M, Leroy A, Pedespan D, Sarda P, Villeneuve N, Schmitz J, van Schaftingen E, Matthijs G, Jaeken J, Korner C, Munnich A, Saudubray JM, Cormier-Daire V. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet. 2001 Jan;38(1):14-9. doi: 10.1136/jmg.38.1.14.
- Grunewald S. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta. 2009 Sep;1792(9):827-34. doi: 10.1016/j.bbadis.2009.01.003. Epub 2009 Jan 14.
- Haeuptle MA, Hennet T. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum Mutat. 2009 Dec;30(12):1628-41. doi: 10.1002/humu.21126.
- Jaeken J, Hennet T, Matthijs G, Freeze HH. CDG nomenclature: time for a change! Biochim Biophys Acta. 2009 Sep;1792(9):825-6. doi: 10.1016/j.bbadis.2009.08.005. No abstract available.
- Krasnewich D, O'Brien K, Sparks S. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia). Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):302-6. doi: 10.1002/ajmg.c.30143.
- Lam C, Krasnewich DM. PMM2-CDG. 2005 Aug 15 [updated 2021 May 20]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1110/
- Monin ML, Mignot C, De Lonlay P, Heron B, Masurel A, Mathieu-Dramard M, Lenaerts C, Thauvin C, Gerard M, Roze E, Jacquette A, Charles P, de Barace C, Drouin-Garraud V, Khau Van Kien P, Cormier-Daire V, Mayer M, Ogier H, Brice A, Seta N, Heron D. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis. 2014 Dec 11;9:207. doi: 10.1186/s13023-014-0207-4.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

